sacituzumab govitecan
gilead sciences
['sacituzumab', 'bcsm', 'breast']
sacituzumab govitecan provides pfs benefit over single-agent chemotherapy in heavily pretreated hr+/her2 metastatic #breastcancer. #asco22 #ascodailynews #bcsm 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ? endorse.